Prevalence of phenotypic familial hypercholesterolaemia and elevated lipoprotein(a) in patients with premature coronary artery disease: implications for developing cardiometabolic services

Coron Artery Dis. 2022 Aug 1;33(5):421-423. doi: 10.1097/MCA.0000000000001129. Epub 2022 Jan 17.

Authors

Russell S Wong¹, Nick S R Lan^{1

2}, James M Rankin¹, Damon A Bell^{2

3

4

5}, Girish Dwivedi^{1

2

6}

Affiliations

¹ Department of Cardiology, Fiona Stanley Hospital.
² Medical School, The University of Western Australia.
³ Departments of Internal Medicine and Cardiology, Royal Perth Hospital.
⁴ Departments of Clinical Biochemistry and Cardiovascular Genetics, PathWest Laboratory Medicine WA, Perth, Royal Perth and Fiona Stanley Hospitals.
⁵ Department of Biochemistry, Clinipath Pathology.
⁶ Harry Perkins Institute of Medical Research, Perth, Australia.

PMID: 35044334
DOI: 10.1097/MCA.0000000000001129

No abstract available

MeSH terms

Cholesterol, LDL
Coronary Artery Disease* / epidemiology
Humans
Hyperlipidemias*
Hyperlipoproteinemia Type II* / diagnosis
Hyperlipoproteinemia Type II* / epidemiology
Hyperlipoproteinemia Type II* / genetics
Lipoprotein(a)
Prevalence

Substances

Cholesterol, LDL
Lipoprotein(a)